Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AVI Products IndiaBOM:523896 39 Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus rates BOM:523896 with a GF Score™ of 39/100 and a GF Value™ of ₹3.54 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 91 Medical Distribution companies, AVI Products India ranks worse than 1098900% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for AVI Products India's Debt-to-EBITDA or its related term are showing as below:
BOM:523896'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.36 Med: 0.87 Max: 3.91
Current: -0.36
During the past 13 years, the highest Debt-to-EBITDA Ratio of AVI Products India was 3.91. The lowest was -0.36. And the median was 0.87.
BOM:523896's Debt-to-EBITDA is ranked worse than 100% of 91
companies
in the Medical Distribution industry
Industry Median: 2.32
vs BOM:523896: -0.36
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
AVI Products India Debt-to-EBITDA Related Terms
AVI Products India Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for AVI Products India's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:523896 vs MCK, COR, CAH: Debt-to-EBITDA Comparison
For the Medical Distribution subindustry, AVI Products India's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVI Products India Debt-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, AVI Products India's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where AVI Products India's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
AVI Products India (BOM:523896) has a Debt-to-EBITDA of 0.00 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on AVI Products India. According to the industry distribution chart, AVI Products India ranks #999999 out of 91 companies in the Medical Distribution industry.
Is AVI Products India's Debt-to-EBITDA too high?
AVI Products India's current Debt-to-EBITDA is 0.00. Based on the distribution chart, AVI Products India ranks #999999 out of 91 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, AVI Products India has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AVI Products India's Debt-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, AVI Products India ranks #999999 out of 91 companies for Debt-to-EBITDA. This places AVI Products India in the lower half of its industry. The industry median Debt-to-EBITDA is 2.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Distribution company?
The median Debt-to-EBITDA among Medical Distribution companies is 2.32, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on AVI Products India. For the Medical Distribution industry, the median Debt-to-EBITDA is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVI Products India's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVI Products India stock overvalued right now?
Based on GuruFocus' analysis, AVI Products India (BOM:523896) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹3.54, compared to a current price of ₹52.40 — trading 1380.2% above its estimated fair value. The current Debt-to-EBITDA is 0.00. AVI Products India's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For AVI Products India (BOM:523896), the current Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AVI Products India (BOM:523896) Overvalued in 2026?
Based on GuruFocus' analysis, AVI Products India stock appears to be overvalued.
The current stock price of ₹52.40 is trading 1380.2% above its estimated GF Value™ of ₹3.54.
GuruFocus considers AVI Products India to be Significantly Overvalued.
Key valuation signals for BOM:523896:
Debt-to-EBITDA: 0.00
GF Value™: ₹3.54 vs. price of ₹52.40 (1380.2% above fair value)
No single metric tells the full story. See the BOM:523896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AVI Products India Ltd is an India-based company that operates in two main segments: E-commerce and Trading, and Food and Beverages. The E-commerce segment distributes dental products like endo-motors, intraoral cameras, curing machines, autoclaves, dental chemicals, and orthodontic materials through Dentaldeal. in. The Food and Beverages segment, under the IFRUIT brand, runs franchises offering ice cream rollies, kulfis, sorbets, sundaes, smoothies, milkshakes, and Belgium waffles. The majority of its revenue comes from e-commerce and Trading.
39GF Score
Get the complete analysis for BOM:523896
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523896 has been successfully added to your 
